1. The number of adults with congenital heart disease (ACHD) is growing due to increased survival of children born with CHD. However, there is minimal guidance on managing ACHD patients in the intensive care unit (ICU).
2. A study of 372 ACHD patients admitted to the ICU found longer lengths of stay, higher resource use, and mortality risks compared to non-ACHD patients. Outcomes varied by complexity of heart condition.
3. Managing ACHD patients in the ICU requires understanding their unique cardiac anatomy and physiology to avoid potential harms from standard interventions and assessments. Special considerations are needed for procedures, monitoring, and treatment.
2010 Guidelines on Thoracic Aortic DiseaseSun Yai-Cheng
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Circulation 2010;121;e266-e369
2010 Guidelines on Thoracic Aortic DiseaseSun Yai-Cheng
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Circulation 2010;121;e266-e369
Overview of preoperative cardiac risk assessmentTerry Shaneyfelt
Basic principles of assessing cardiac risk in patients undergoing noncardiac surgery. Audience: general internists and family practitioners. Watch my YouTube video describing these slides: http://youtu.be/AAGgwU0uXj0
Cardiovascular risk evaluation and management before renal transplantation sl...Christos Argyropoulos
Presentation focused on pre-operative evaluation of Major Adverse Cardiac Events prior to renal transplantation.
Modified from a presentation I gave in 2007; compared to the original there is a less enthusiastic endorsement of a peri-operative fixed dose beta blockade administration strategy given the discrepant results of the POISE and DECREASE-II studies
Anaesthesia in Cardiac Patients for Non-cardiac SurgeryRashad Siddiqi
The reader should be able to:
(1) identify factors which will lead to increased cardiovascular risk for patients undergoing non-cardiac surgery
(2) decide which patients require further cardiovascular testing
(3) make optimization plan for such patients
(4) understand the principles of anaesthesia for patients with cardiac disease
Overview of preoperative cardiac risk assessmentTerry Shaneyfelt
Basic principles of assessing cardiac risk in patients undergoing noncardiac surgery. Audience: general internists and family practitioners. Watch my YouTube video describing these slides: http://youtu.be/AAGgwU0uXj0
Cardiovascular risk evaluation and management before renal transplantation sl...Christos Argyropoulos
Presentation focused on pre-operative evaluation of Major Adverse Cardiac Events prior to renal transplantation.
Modified from a presentation I gave in 2007; compared to the original there is a less enthusiastic endorsement of a peri-operative fixed dose beta blockade administration strategy given the discrepant results of the POISE and DECREASE-II studies
Anaesthesia in Cardiac Patients for Non-cardiac SurgeryRashad Siddiqi
The reader should be able to:
(1) identify factors which will lead to increased cardiovascular risk for patients undergoing non-cardiac surgery
(2) decide which patients require further cardiovascular testing
(3) make optimization plan for such patients
(4) understand the principles of anaesthesia for patients with cardiac disease
Geriatric anesthesia with special consideration Petrus IitulaPetrus Iitula
With age, comes changes in normal physiological functions of the body and different diseases are picked up in certain population groups as we age. all this factors predisposes the geriatric population to certain complications once under anesthesia. Hence anesthetic preparation for the geriatric patients is needed to avoid mortality and morbidity in this population.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
4. • 80-85% patients born with CHD survive to adulthood
• 106 patients >20 years with ACHD in USA
• Predicted increase 1,600 per annum in UK (moderate-severe)
• Many at complex end of spectrum:
• Lifelong follow-up
• Repeat surgical and electrophysiological interventions
• Increasing surgical burden (complexity)
Warnes CA, JACC 2001, Wren J, Heart 2001, Somerville J, Heart 2002
ACHD/GUCH
10. • Guidelines recognise special requirements
• Staffing
• Transition clinics
• Specialised services
• Training and education
• No comments regarding critical care
• No recognition of acute management
• No guidelines regarding emergency management
• No ACHD in ICU training
• No ICU training in ACHD
• No guidance regarding impact of expansion on ICU
Guidelines
11.
12.
13. • More patients
• More complex
• Changing interventions
• No guidance/minimal guidance regarding ICU management
A growing problem?
27. • More patients
• More complex
• Changing interventions
• No guidance/minimal guidance regarding ICU management
• Scoring systems don’t help
• Resource-intensive – interventions and financial
A growing problem?
30. 1. Know the cardiopulmonary anatomy
2. Know the normal physiology of your patient
3. Understand how supportive/interventional therapies might affect the
circulation
4. Anticipate the particular potential pitfalls related to ICU
monitoring/interventions
Basic principles for approaching the critically ill GUCH patient
32. Parameter Previous intervention/pathology Comment
Blood pressure Previous classical/modified BT shunt Will under-read. Place catheter/cuff on contralateral
arm
Previous bilateral shunts Lower body pressure measurements more accurate
Previous Coarctation/residual Coarctation, previous
femoral bypass/multiple cardiac catheterisations
Lower limb pressures under-represent central
pressure
Radial line cannulation/surgical cutdown (esp
neonatal)
Ulnar dominant/absent radial artery. Cuff accurate,
avoid ulnar cannulation
Circulating volume Cyanotic ACHD Tolerate hypovolaemia poorly
Univentricular heart Tolerate hypovolaemia poorly, but may have
significantly impaired ventricular function/AV valve
regurgitation
Fontan/TCPC “CVP” often misleading as represents pulmonary
artery pressures
Pulmonary vein stenosis Basal crepitations not indicative of systemic
ventricular failure
Pulse oximetry Compromised arterial supply / systemic hypotension Digital oximeters may be unreliable, use central
oximetry (ear lobe sensors/reflectance oximeters)
Cyanotic ACHD Oximetry may be inaccurate (calibrated to be
accurate at SpO2 >80%)
Cardiac output Tricuspid/pulmonary atresia/Fontan/TCPC PA catheter placement not possible
Intra/extra-cardiac shunts PA catheter unreliable
Chronic low CO state Oesophageal Doppler unreliable (small aorta)
Pacing Multiple previous access, cutdowns etc Expert in access required
Fontan, TCPC, tricuspid/pulmonary atresia Standard trans-venous pacing is not possible. In an
emergency transcutaneous pacing may be required.
ECG Massive atrial enlargement and univentricular
circulation
Atrial tachycardia may be disguised as sinus
tachycardia. High index of suspicion, comparison with
previous ECGS, CSM/adenosine/pacemaker
interrogation may be useful
INR Cyanotic patients If haematocrit >60, need citrate adjusted samples for
accurate measurement
Principles: assessment & monitoring
34. Intended intervention/diagnosis Comment
Associated anatomical defects Asplenia/polysplenia
GI/renal malformation
Cyanotic congenital heart disease Associated renal impairment is common
Enteral feeding Severe right heart failure may necessitate low feeding rates
Tolerance to fluid loading/restriction • Univentricular circulations may require relatively full
intravascular volume (beware though AV valve regurgitation)
• Acute right heart dilatation may occur (e.g. Ebstein’s anomaly)
Liver function Abnormal liver function tests common post-operatively, and are
associated with increased mortality
Thyroid function Commonly abnormal in GUCH
Haemoglobin Cyanotic congenital heart disease associated with erythrocytocis
and may require a more liberal transfusion policy
GASTROINTESTINAL/
METABOLIC
Intended intervention/diagnosis Comment
Absent or abnormal connections Expected (e.g Fontan/TCPC)
Unexpected (e.g. persistent left superior vena cava)
Multiple previous cannulations/interventions Challenging vascular access
Potential/actual right-left shunting Air filters required on all lines
Cardiac output measurement • Intracardiac shunt may complicate
• Absent pulmonary artery/right-sided connection
• Small aorta may invalidate oesophageal Doppler measurements
Transvenous pacing Consider access routes to right heart as may be absent (e.g
Fontan/TCPC)
Vasoactive drugs Differential effects on systemic and pulmonary vasculature:
Unpredictable
May affect cardiac output and saturations
CARDIOVASCULAR
Intended intervention/diagnosis Comment
Intubation Carniofacial abnormalities in associated syndromes may
complicate the process
Tracheostomy Presence of collateral blood vessels
Abnormal neck and/or airway anatomy
Associated congenital pulmonary disease Hypoplastic lung
Severe congenital V/Q mismatch
Lung reperfusion injury post-operatively ALI/ARDS-like picture, which may be unilateral/bilateral
Pulmonary hypertension May not need treating per se
In presence of inadequate cardiac output may require pulmonary
vasodilators (inhaled/nebulised/intravenous/oral)
Previous cardiac surgery Possibility of phrenic nerve palsy
Difficulty with ventilatory weaning Associated congenital musculoskeletal deformities not uncommon
PULMONARY
35. Intended intervention/diagnosis Comment
Associated anatomical defects Asplenia/polysplenia
GI/renal malformation
Cyanotic congenital heart disease Associated renal impairment is common
Enteral feeding Severe right heart failure may necessitate low feeding rates
Tolerance to fluid loading/restriction • Univentricular circulations may require relatively full
intravascular volume (beware though AV valve regurgitation)
• Acute right heart dilatation may occur (e.g. Ebstein’s anomaly)
Liver function Abnormal liver function tests common post-operatively, and are
associated with increased mortality
Thyroid function Commonly abnormal in GUCH
Haemoglobin Cyanotic congenital heart disease associated with erythrocytocis
and may require a more liberal transfusion policy
GASTROINTESTINAL/
METABOLIC
Intended intervention/diagnosis Comment
Absent or abnormal connections Expected (e.g Fontan/TCPC)
Unexpected (e.g. persistent left superior vena cava)
Multiple previous cannulations/interventions Challenging vascular access
Potential/actual right-left shunting Air filters required on all lines
Cardiac output measurement • Intracardiac shunt may complicate
• Absent pulmonary artery/right-sided connection
• Small aorta may invalidate oesophageal Doppler measurements
Transvenous pacing Consider access routes to right heart as may be absent (e.g
Fontan/TCPC)
Vasoactive drugs Differential effects on systemic and pulmonary vasculature:
Unpredictable
May affect cardiac output and saturations
CARDIOVASCULAR
36. Intended intervention/diagnosis Comment
Associated anatomical defects Asplenia/polysplenia
GI/renal malformation
Cyanotic congenital heart disease Associated renal impairment is common
Enteral feeding Severe right heart failure may necessitate low feeding rates
Tolerance to fluid loading/restriction • Univentricular circulations may require relatively full
intravascular volume (beware though AV valve regurgitation)
• Acute right heart dilatation may occur (e.g. Ebstein’s anomaly)
Liver function Abnormal liver function tests common post-operatively, and are
associated with increased mortality
Thyroid function Commonly abnormal in GUCH
Haemoglobin Cyanotic congenital heart disease associated with erythrocytocis
and may require a more liberal transfusion policy
GASTROINTESTINAL/
METABOLIC
37. Diagnosis Potential pitfall
Cyanotic Under-recognition of diuretic requirements
Severe hyperkalaemia post-contrast
Failing sub-pulmonary ventricle Under-diagnosis of pulmonary hypertension
Univentricular heart Unpredictable response to all interventions
Balance of pulmonary vs systemic flow difficult
Interpretation of hypoxaemia difficult
Coarctation GI ischaemia associated with enteral feeding
ASD Over-treatment of PHT
Inadequate HR
AVSD LVOTO
TOF Reperfusion pulmonary oedema
Under-recognition of RV dysfunction
Under-recognition of LV dysfunction
Ebstein’s Difficult to measure CO
Arrhythmias difficult to diagnose and treat
Shunts Difficult to measure BP accurately
Anaesthetic hypotension: reduce pulmonary flow
Pulmonary hypertension Avoid venesection
Avoid hypocapnia
Fontan Arrhythmias difficult to diagnose and treat
CO difficult to measure
Balance benefits vs harm from IPPV
Fenestrated: hypoxia difficult to assess
Anaesthesia may cause haemodynamic collapse
Fluid loading may cause severe MR
Additional pitfalls
38. • As in acquired cardiac disease
• CAD considered rare anecdotally
• Ageing population
• Arterial switch
• Four specific scenarios to consider:
• Left sided (systemic) failure
• Right sided (sub-pulmonary) failure
• Univentricular heart
• Systemic right ventricle
Even ‘heart failure’ is different
39. • Many pitfalls with respect to cardiac intensive care
• Differs from paediatric intensive care
• Implications for:
• Funding
• Theatre scheduling
• ICU bed occupancy
• Availability of investigations requiring specialist expertise
• Training
• Staffing
• Supervision of junior staff
• If familiar with GUCH, easy to under-estimate the challenge for non-congenital
ICU teams
• Interesting and outcomes are good
GUCH intensive care
40. • More patients
• More complex
• Changing interventions
• No guidance/minimal guidance regarding ICU management
• Scoring systems don’t help
• Resource-intensive – interventions and financial
• Critical care of the GUCH patient?
• Challenging
• Very different
• Evidence-free zone
• Little guidance
• Few centres for training
A growing problem?